Lipid metabolism in relation to cold adaptability in man.

S. Itoh,A. Kuroshima,K. Doi,K. Moriya,H. Shirato,K. Yoshimura

1969-05-01

Abstract:

What problem does this paper attempt to address?

Serotonin axons in the supra- and subependymal plexuses and in the leptomeninges; Their roles in local alterations of cerebrospinal fluid and vasomotor activity

V. Chan‐Palay

DOI: https://doi.org/10.1016/0006-8993(76)90578-3

IF: 3.61

1976-01-30

Brain Research

Abstract:
Effect of Membrane Surface Modification Using Chitosan Hydrochloride and Lactoferrin on the Properties of Astaxanthin-Loaded Liposomes

Mengdan Qiang,Xiao Pang,Dexue Ma,Cuicui Ma,Fuguo Liu

DOI: https://doi.org/10.3390/molecules25030610

IF: 4.6

2020-01-30

Molecules

Abstract:Astaxanthin-loaded liposomes were prepared by a thin-film ultrasonic method, and the effects of the different membrane surface modifiers chitosan hydrochloride (CH) and lactoferrin (LF) on the physicochemical stability of the liposomes and bioaccessibility of astaxanthin were studied. Based on the negative charge characteristics of egg yolk lecithin, LF and CH with positive charge were assembled on the surface of liposomes by an electrostatic deposition method. The optimal concentrations of modifiers were determined by particle size, zeta potential and encapsulation efficiency. The interaction between the liposomes and the coatings was characterized by Fourier Transform infrared spectroscopy. The stability of astaxanthin in different systems (suspension and liposomes) was investigated, and its antioxidant capacity and bioaccessibility were determined. The results showed that both membrane surface modifications could interact with liposomes and protect astaxanthin from oxidation or heat degradation and enhance the antioxidant activity of the liposome, therefore membrane surface modification played an important role in stabilizing the lipid bilayer. At the same time, the encapsulated astaxanthin exhibited higher in vitro bioaccessibility than the free astaxanthin. CH and LF modified liposomes can be developed as formulations for encapsulation and delivery of functional ingredients, providing a theoretical basis for the development of new astaxanthin series products.

chemistry, multidisciplinary,biochemistry & molecular biology
Surface modification by chitosan for improving stability and antioxidative activity of astaxanthin-loaded liposomes

Xinping Zhang,Zijian Wu,Wen Zhang,Limin Wang,Pei Zhao,Xinyi Lv,Peibo Guo,Jinyu Chen

DOI: https://doi.org/10.1016/j.lwt.2024.116033

2024-04-04

Abstract:Astaxanthin (AST) is a compound renowned for its extraordinary antioxidant and anti-inflammatory properties. However, its application is limited due to low solubility, instability and bioavailability. To overcome these drawbacks, we encapsulated AST in liposomes (AST-loaded liposomes, AST-LIP) using chitosan (CS) as coating materials by thin film dispersion and high-pressure homogenization. We examined the physicochemical characteristics (particle size, polydispersity index, zeta potential, encapsulation efficiency, fourier transform infrared spectroscopy (FT-IR), and thermogravimetric analyzer (TGA)) of AST-LIP coated with various concentrations of CS, and confirmed the optimal concentration for the formulation of CS-coated AST-LIP was 1.5 mg/mL. Additionally, the storage stability and thermal stability analysis revealed that CS-AST-LIP exhibited significantly higher AST retention rates than AST-LIP under varying environmental conditions. Furthermore, CS-AST-LIP showed significantly higher DPPH·, OH· radical scavenging effects, and iron-reducing power than AST-LIP after storage for 4 weeks at 4 °C. For the cellular antioxidant assays, the CS-AST-LIP at the CS concentration of 1.5 mg/mL exhibited a satisfactory protective effect against oxidative damage induced by H 2 O 2 in Raw264.7 cells. In conclusion, these findings highlight the potential of chitosan as a promising coating material for improving the storage stability, thermal stability and antioxidant activity of AST-LIP.
Design of Astaxanthin-Loaded Core-Shell Nanoparticles Consisting of Chitosan Oligosaccharides and Poly(lactic- co-glycolic acid): Enhancement of Water Solubility, Stability, and Bioavailability.

Chengzhen Liu,D. Mcclements,Ying Xu,Dongfeng Wang,Shuaizhong Zhang

DOI: https://doi.org/10.1021/acs.jafc.8b06963

IF: 6.1

2019-04-23

Journal of Agricultural and Food Chemistry

Abstract:Astaxanthin, a hydrophobic carotenoid found in marine plants and animals, is claimed to exhibit various beneficial biological activities. Its use as a nutraceutical in foods, however, is currently limited by its low water-solubility and poor bioavailability. The goal of this paper was to fabricate astaxanthin-loaded colloidal particles to overcome these challenges. Astaxanthin was encapsulated in poly(lactic- co-glycolic acid) (PLGA) nanoparticles coated with chitosan oligosaccharides (COS). The properties of the loaded nanoparticles were characterized by transmission electron microscopy, scanning electron microscopy, and dynamic light scattering. The influence of PLGA properties on the loading capacity, water solubility, stability, and release of the astaxanthin were determined. The nanoparticles were smooth spheres with mean particle diameters around 150 nm and positive surface potentials (ζ = +30 mV). The encapsulation efficiency (>85%) and loading capacity (>15%) of the astaxanthin in the nanoparticles was relatively high. X-ray analysis suggested that the encapsulated astaxanthin was in an amorphous form. The nanoparticles had good dispersibility and stability in aqueous solutions, as well as high cytocompatibility. In vitro studies showed that the astaxanthin was released from the nanoparticles under simulated gastric and small intestinal conditions. Overall, our results suggest the core-shell nanoparticles developed in this study may be suitable for encapsulating this important nutraceutical in functional foods and cosmetics.

Chemistry,Medicine,Materials Science
Prevention of Hypercholesterolemia with "Liposomes in Microspheres" Composite Carriers: A Promising Approach for Intestinal-Targeted Oral Delivery of Astaxanthin

Aiyang Liu,Mengxue He,Chunhuan Liu,Zhan Ye,Chin-Ping Tan,Yanjun Liu,Jiajia Gong,Jingnan Lei,Yuan He,Shuang Zhu,Jialiang Zhao,Yong-Jiang Xu,Yuanfa Liu

DOI: https://doi.org/10.1021/acs.jafc.3c08697

2024-03-27

Abstract:Cardiovascular diseases are caused by hypercholesterolemia. Astaxanthin (AST) has been reported to exhibit antioxidant and anti-inflammatory properties. However, its bioavailability is poor because of low solubility and instability. In order to improve the bioavailability of AST, we developed an intestinal-responsive composite carrier termed as "liposomes in micropheres" incorporating N-succinyl-chitosan (NSC)-poly(ethylene glycol) (PEG) liposomes that functionalized by neonatal Fc receptors (FcRn) into hydrogels of sodium alginate (SA) and carboxymethyl chitosan (CMCS). In the AST NSC/HSA-PEG liposomes@SA/CMCS microspheres, the AST's encapsulation efficiency (EE) was 96.26% (w/w) and its loading capacity (LC) was 6.47% (w/w). AST NSC/HSA-PEG liposomes had stability in the gastric conditions and achieved long-term release of AST in intestinal conditions. Then, AST NSC/HSA-PEG liposomes@SA/CMCS bind to intestinal epithelial cell targets by the neonatal Fc receptor. In vitro permeation studies show that there was a 4-fold increase of AST NSC/HSA-PEG liposomes@SA/CMCS in AST permeation across the intestinal epithelium. Subsequent in vivo experiments demonstrated that the composite carrier exhibited a remarkable mucoadhesive capacity, allowing for extended intestinal retention of up to 12 h, and it displayed deep penetration through the mucus layer, efficiently entering the intestinal villi epithelial cells, and enhancing the absorption of AST and its bioavailability in vivo. And oral administration of AST NSC/HSA-PEG liposomes@SA/CMCS could effectively prevent hypercholesterolemia caused by a high-fat, high-cholesterol diet (HFHCD). These advancements highlight the potential of NSC/HSA-PEG liposomes@SA/CMCS composite carriers for targeted and oral uptake of hydrophobic bioactives.
Enhancement of Astaxanthin Bioaccessibility by Encapsulation in Liposomes: An In Vitro Study

Li Pan,Haojie Meng,Jiaqi Li,Zongjie Liu,Dongsheng Zhang,Zhengyang Liu,Qian Zhao,Fei Xu

DOI: https://doi.org/10.3390/molecules29081687

IF: 4.6

2024-04-10

Molecules

Abstract:Astaxanthin was encapsulated in liposomes by a thin layer dispersion and ultrasound method using soybean phospholipid. The digestion properties of liposomes for encapsulating astaxanthin were investigated in light of particle size, size distribution, zeta potential, and microstructure during in vitro digestion as a function of time. These results exhibited that the average particle size increased gradually with liposomal vesicles retained round shapes and a fairly uniform distribution after passage through the simulated gastric fluid digestion. The result revealed that astaxanthin-loaded liposomes were stable in low pH conditions. It was also found that the mixed micelles formed in a simulated intestinal fluid. The zeta potential of astaxanthin-loaded liposomes had a decrease in negativity after digestion. In comparison with free astaxanthin, there was an appreciable increase in the bioaccessibility of astaxanthin after encapsulation in liposomes. This enhancement can be attributed to more soluble astaxanthin in the mixed micelles for astaxanthin-loaded liposomes. It indicated that the barrier of the liposomal bilayer could inhibit astaxanthin fading and leaking after encapsulation in liposomes. These results provide useful information for designing more stable delivery systems in the gastrointestinal tract and improving the bioaccessibility of lipophilic nutraceuticals.

chemistry, multidisciplinary,biochemistry & molecular biology
Preparation, characterization, and stability of chitosan-tremella polysaccharide layer-by-layer encapsulated astaxanthin nanoemulsion delivery system

Yunbo Ge,Xinjian Jiang,Wenbo Peng,Yuting Liu,Yuanhong Ge,Zihao Wang,Yating Wang,Wenhui Wu,Chaoyan Zhang

DOI: https://doi.org/10.1016/j.ijbiomac.2024.136741

IF: 8.2

2024-10-21

International Journal of Biological Macromolecules

Abstract:In this study, a layer-by-layer (LBL) encapsulated astaxanthin (Ast) nanoemulsion delivery system based on chitosan (CS) and tremella polysaccharide (TP) was successfully developed. The system constructed an Ast-CS-TP emulsion with high encapsulation efficiency and an excellent stability profile by utilizing the opposite charge properties of CS and TP. This study evaluated the effects of different stresses (including temperature, salt addition, pH, UV irradiation, and centrifugal force) on the emulsion's stability. To further investigate the protective mechanism of the emulsions, we performed antioxidant activity experiments after UV treatment. Additionally, an in vitro digestion experiment was conducted to assess the behavior of Ast emulsion under simulated gastrointestinal conditions. The stability correlation coefficients were calculated using the Python database Pandas. The results showed that Ast-CS-TP emulsions exhibited turbidity and enhanced homogeneity with a small particle size of around 400 nm and a high absolute zeta potential of 35 mV and exhibited excellent stability under various stresses. The Ast-CS-TP emulsions also exhibited pH-responsive release at pH ≥ 7, consistent with pH changes in the gastrointestinal tract, and were stable in highly concentrated salt solutions. We found that the CS and TP layers significantly improved the photostability of Ast. CS and TP significantly enhanced Ast's oral bioavailability. The stability correlation coeffcients showed that pH and salt concentration were the largest factors that affected the stability of the emulsion. This study provided important insights into the encapsulation and targeting of Ast, providing a theoretical foundation and technical guidance for the comprehensive utilization of Ast.

polymer science,biochemistry & molecular biology,chemistry, applied
On trigonometric and paratrigonometric Hermite interpolation

Jinyuan Du,Huili Han,G. Jin

DOI: https://doi.org/10.1016/j.jat.2004.09.005

IF: 0.993

2004-11-01

Journal of Approximation Theory

Abstract:
Extraction of Astaxanthin from Haematococcus pluvialis and Preparation of Astaxanthin Liposomes

Fei Luo,Shuai Wang,Xuwu Zhang,Zhiwei Liu,Ruiyan Zhu,Weili Xue

DOI: https://doi.org/10.3390/molecules29143320

IF: 4.6

2024-07-15

Molecules

Abstract:Astaxanthin has 550 times more antioxidant activity than vitamin E, so it can scavenge free radicals in vivo and improve body immunity. However, the poor stability of astaxanthin becomes a bottleneck problem that limits its application. Herein, Haematococcus pluvialis (H. pluvialis) as a raw material was used to extract astaxanthin, and the optimal extraction conditions included the extraction solvent (EA:EtOH = 1:6, v/v), extraction temperature (60 °C), and extraction time (70 min). The extracted astaxanthin was then loaded using lecithin to form corresponding liposomes via the ethanol injection method. The results showed that the particle size and zeta potential of the prepared liposomes were 105.8 ± 1.2 nm and −38.0 ± 1.7 mV, respectively, and the encapsulation efficiency of astaxanthin in liposomes was 88.83%. More importantly, the stability of astaxanthin was significantly improved after being embedded in the prepared liposomes.

chemistry, multidisciplinary,biochemistry & molecular biology
Lyotropic Liquid Crystal System for Drug Delivery of Astaxanthin: Physical Characterization and Enhanced Antioxidant Potential

Sapna Kumari,Anju Goyal,Madhukar Garg,Angela Antonescu,Rakesh K. Sindhu

DOI: https://doi.org/10.3390/cryst13010142

IF: 2.7

2023-01-14

Crystals

Abstract:Astaxanthin is a xanthophyll carotenoid, well known for its potent anti-inflammatory and antioxidant properties, owing to its unsaturated molecular structure. Aquatic plants and animals contain the hydrophobic carotenoid astaxanthin, which is thought to possess a number of advantageous biological traits. However, due to its weak bioavailability and low water solubility, its use as a nutraceutical in food is currently restricted. Cubosomal encapsulation has been considered an effective alternative for improving the bioavailability and solubility of hydrophobic bioactives. The current paper aimed to conquer these issues by encapsulating astaxanthin in lyotropic liquid crystal nano-formulations prepared via the fabrication method. The physicochemical properties of astaxanthin-loaded cubosomes (AST-LC) have also been analyzed, in order to know the morphology of the prepared formulations and their bioavailability in the biological system. The formulation has been tested for particle size, thermal behavior, zeta potential, crystallinity, encapsulation efficiency, and drug-polymer interactions. The observed experimental results showed the particle size and zeta potential of astaxanthin-loaded cubosomes (AST-LC) as 199 ± 0.23 nm −27.4 ± 4.67 mV, with a small polydispersity index (0.283 ± 1.01). The cubic structure and nano-range size of the ideal formulation were verified by a field emission scanning electron microscope (FESEM) and (HRTEM) high-resolution transmission electron microscopic examination. The formulation exhibits a higher encapsulation efficiency with good yield. Results from X-ray diffraction and diffraction scanning calorimetry demonstrated an amorphous state of astaxanthin incorporated into the formulation. Fourier transform infrared spectroscopy (FTIR) analysis of AST-LC showed the absence of astaxanthin main peaks, indicating its complete encapsulation inside the formulation. The drug–excipient interaction was carried out with diffraction scanning calorimetry DSC and FTIR, resulting in no interaction between them. These results offered important details about increasing astaxanthin bioavailability by incorporating it into cubosomes. Furthermore, the astaxanthin loaded into cubosomes has been evaluated for antioxidant potency, compared with astaxanthin extract using 2,2-diphenylpicrylhydrazylassay (DPPH assay).

materials science, multidisciplinary,crystallography
Nanostructured Lipid Carriers in Alginate Microgels for the Delivery of Astaxanthin

Juan Huang,Wenjing Xie,Lu Liu,Yucong Song,Fang Pan,Hua Bai,Ting Pan,Yiwen Lv,Jianchu Chen,Jianqiang Shi,Xiaojia Hu

DOI: https://doi.org/10.1002/ejlt.202000191

2021-01-01

European Journal of Lipid Science and Technology

Abstract:This study aims to enhance the stability and bioavailability of astaxanthin by loading it into nanostructured lipid carriers (NLCs), then incorporating the NLCs into alginate microgels. The NLCs (about 200 nm particle size) and alginate microgels (about 1 mm particle size) are prepared using high-pressure homogenization and injection-gelation methods, respectively. Based on in vitro dissolution assessments, the astaxanthin in alginate microgels dissolves more slowly than that in NLCs. In simulated gastric digestive juice, minimal dissolution of microgel-embedded astaxanthin is detected; however, in simulated intestinal digestive juice, the dissolution is appreciably accelerated. Moreover, the 2 h bio-accessibility of astaxanthin in microgels is less than that in NLCs. At higher concentrations of sodium alginate and calcium ions, the internal pores of the microgels become smaller, resulting in slower dissolution and lower bio-accessibility of astaxanthin. As for the chemical stability of the pigment, it is improved by the secondary coating effect of hydrogelation. Hence, NLC incorporation into alginate microgels constitutes a promising strategy for the encapsulation of astaxanthin in the food industry. Practical applications : Nanostructured lipid carriers (NLCs) incorporated in alginate microgels can increase the water solubility of astaxanthin, improve its chemical stability, increase its bioavailability, and allow for its controlled release. The high-pressure homogenization method used to prepare NLCs can be easily applied on an industrial level. Moreover, the operation conditions of the injection-gelation process needed to synthesize the alginate microgels are mild, nontoxic, and nonpolluting. The NLC-alginate microgels can be used in yogurt, ice cream, and other foods.
Preparation of astaxanthin/zeaxanthin-loaded nanostructured lipid carriers for enhanced bioavailability: Characterization-, stability-and permeability study

Kristina Radić,Ana Isabel Barbosa,Salette Reis,Marijan Marijan,Sofia Antunes Costa Lima,Dubravka Vitali Čepo

DOI: https://doi.org/10.2478/acph-2023-0038

2023-12-26

Abstract:Astaxanthin (ASTA) and zeaxanthin (ZEA) are xanthophyll carotenoids showing a wide spectrum of health-promoting properties. However, their utilization is limited, mostly due to poor water solubility, limited bioavailability, and a tendency to oxidate, as well as photo- and thermal instability. The aim of this work was to develop ASTA- and ZEA-loaded nano-structured lipid carriers (NLCs) that would protect them against degradation and improve their intestinal stability/permeability. Obtained NLCs were characterized by an effective diameter of 294 nm for ASTA-NLC and 280 nm for ZEA-NLC; polydispersity index (PDI) lower than 0.2; and zeta potential of -29.4 mV and -29.0 mV, respectively. Interestingly, despite similar physicochemical characteristics, our investigation revealed differences in the encapsulation efficiency of ASTA-NLC and ZEA-NLC (58.0 % vs. 75.5 %, respectively). Obtained NLCs were stable during a 21 day-storage period in the dark at room temperature or at 4 °C. Investigation of gastrointestinal stability showed no change in effective diameter and PDI under gastric conditions while both parameters significantly changed under intestinal conditions. Our results showed for the first time that both ASTA- and ZEA-NLCs intestinal absorption investigated in the in vitro model is significantly increased (in relation to pure compounds) and is affected by the presence of mucus. This study provides useful data about the advantages of using NLC as a delivery system for ASTA and ZEA that might facilitate their applications in the food and pharmaceutical industry.
Preparation of cellulose-based nanoparticles via electrostatic self-assembly for the pH-responsive delivery of astaxanthin

Miaoyu Gan,Ailing Cao,Luyun Cai,Xia Xiang,Jian Li,Qian Luan

DOI: https://doi.org/10.1016/j.foodchem.2024.141324

2024-09-18

Abstract:Oral administration of astaxanthin (AST), a potent antioxidant, is limited owing to its low solubility, physicochemical stability, and bioavailability. This study developed pH-responsive nanocarriers by the electrostatic self-assembly of 2,2,6,6-tetramethylpiperidine-1-oxyradical (TEMPO)-oxidized cellulose nanofibers (TCNFs) and chitosan (CS) to enhance the intestinal delivery of AST. The TCNF/CS@AST nanoparticles were optimized through single-factor experiments and Box-Behnken design, subsequently overcoming the hydrophobicity of AST and demonstrating improved stability against environmental stressors and controlled release in the intestinal environment. Transmission electron microscopy confirmed the near-spherical shape of these nanoparticles, with an average hydrodynamic diameter of 64 nm. TCNF/CS@AST enhanced the antioxidant effectiveness of AST after digestion and in lipopolysaccharide-stimulated RAW 264.7 cells while demonstrating good cellular compatibility. These nanoparticles present a promising strategy for the oral delivery of hydrophobic bioactive compounds orally, with potential applications in precision nutrition.
Emotional reactions and life changes of caregivers of demented patients when home caregiving ends

U. Eloniemi-Sulkava,Terhi Rahkonen,M. Suihkonen,P. Halonen,M. Hentinen,R. Sulkava

DOI: https://doi.org/10.1080/1360786021000006965

2002-11-01

Aging & Mental Health

Abstract:Many studies indicate that the cessation of caregiving of demented patients has positive effects on caregivers' lives but contradictory findings have also been reported. The aim of this study was to investigate how the caregivers of demented patients experienced the cessation of caregiving, how caregivers' lives changed after this event, and which factors predicted emotional reactions and life changes. Data were collected from 64 caregivers of demented patients, recruited from a previous controlled intervention study. The semi-structured telephone interviews sought (1) sociodemographic data, (2) emotional reactions the caregivers recalled from the point of cessation of caregiving, and (3) life changes experienced after that time point. At the point of cessation of caregiving, spouse caregivers had higher risk for loneliness, depressive feelings and sorrow than non-spouse caregivers. Feelings of relief were associated with non-spouses. Community care support obtained during the previous intervention study had protected the caregivers from loneliness, depressive feelings and sorrow. After the end of caregiving, spouse caregivers tended to experience more negative life changes. The increased number of leisure activities was associated with the support during community care.
Development of a carboxymethyl chitosan functionalized nanoemulsion formulation for increasing aqueous solubility, stability and skin permeability of astaxanthin using low-energy method

Liang Hong,Chuan-Li Zhou,Feng-Ping Chen,Dan Han,Chun-Yuan Wang,Jia-Xin Li,Zhe Chi,Chen-Guang Liu

DOI: https://doi.org/10.1080/02652048.2017.1373154

2017-11-15

Journal of Microencapsulation

Abstract:In this research, firstly astaxanthin (ASX)-loaded nanoemulsions (NEs) were produced using a convenient low-energy emulsion phase inversion method. The optimised ASX-NEs were prepared in the presence of Cremophor® EL and Labrafil® M 1944 CS, with a surfactant-to-oil ratio of 4:6. The ASX-NE droplets were spherical with a mean droplet diameter below 100 nm and a small negative surface charge. The system was stable without alteration of mean droplet diameter for three months. Then, the ASX-NE was functionalised with carboxymethyl chitosan (CMCS) through direct CMCS (0.02%) incorporation during the preparation process. The ASX chemical stability and skin permeability increased in the following order: ASX solution control < ASX-NE < CMCS-ASX-NE. Cell viability assays on L929 cells revealed low cytotoxicity of blank NE, ASX-NE and CMCS-ASX-NE in the range from 5 to 500 μg mL-1. In conclusion, the CMCS-ASX-NE might be a promising delivery vehicle in dermal and transdermal products.

pharmacology & pharmacy,chemistry, applied,engineering, chemical
Preparation, characterization and antioxidant activity of astaxanthin esters with different molecular structures

Lu Yang,Xing Qiao,Jing Liu,Lulu Wu,Yunrui Cao,Jie Xu,Changhu Xue

DOI: https://doi.org/10.1002/jsfa.10887

Abstract:Background: Astaxanthin (Asta) is widely used in the nutraceutical and food industry because of its strong antioxidant properties. However, natural Asta mainly exists in the esterified form with various fatty acid chains, making it difficult to understand the particular molecular structure of astaxanthin esters (Asta-Es) that have better antioxidant capacity. In this study, Asta-Es with different molecular structures was systematically prepared, and identified by using thin-layer chromatography (TLC), ultraviolet-visible (UV-visible), high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS), and proton nuclear magnetic resonance (1 H-NMR). In addition, their antioxidant properties were evaluated by 2,2'-diphenylpicrylhydrazyl (DPPH) and ABTS scavenging activity. Results: Fourteen Asta-Es with different molecular structures were systematically synthesized. This study used a simple and efficient method for the separation and purification of astaxanthin monoester (Asta-ME) and astaxanthin diester (Asta-DE) with high purity (86%-94%) by silica gel column chromatography. 13-cis-Asta-E and 9-cis-Asta-E were firstly identified from Asta-E. The DPPH clearance rates and ABTS scavenging rates of Asta-C4:0, Asta-C8:0, Asta-C12:0, and Asta-C18:0 were relatively close, but the DPPH and ABTS scavenging rates of Asta-C18:0, Asta-C18:1, Asta-C18:2, and Asta-C22:6 increased gradually. Among all Asta-Es, Asta-C22:6/C22:6 showed the highest antioxidant capacity, with the DPPH and ABTS scavenging rates of 77.22 ± 3.29% and 51.84 ± 1.65%, respectively. Conclusion: In this study, it was concluded that chemically synthesized Asta-Es contained cis-astaxanthin ester and polyunsaturated fatty acid chain increased the antioxidant activity of Asta, showing less effect of the length of fatty acid chain. These results provide useful information for the production and use of highly efficient Asta-E as functional food and pharmaceutical ingredients. © 2020 Society of Chemical Industry.
Astaxanthin encapsulation in nanocapsule by high-pressure homogenization technology: a study on stability, antioxidant activity and in vitro release

Liyuan Gu,Suping Ji,Bi Wu,Wenjuan Wang,Jingfang Cheng,Qiang Xia

DOI: https://doi.org/10.1080/01932691.2023.2199830

2023-04-23

Journal of Dispersion Science and Technology

Abstract:The astaxanthin nanocapsules (ASX-LNC) was prepared by high-pressure homogenization technology, the microstructure, stability, antioxidant activity, and in vitro release characteristics of ASX-LNC were characterized and evaluated. The ASX-LNC comprised a core material and wall materials. The core material was composed of astaxanthin oil, and the wall materials were composed of β-cyclodextrin, decapolyglycerol monooleate, soybean lecithin (PC60), glycerol, and deionized water. The mean particle size of the ASX-LNC was 206.9 ± 2.8 nm, and the polydispersity index (PdI) value was 0.218 ± 0.026. The zeta potential of ASX-LNC was −26.16 ± 0.87 mV. The loading amount of ASX-LNC was 0.546%±0.032%, and the encapsulation efficiency was 99.65%±0.13%, indicating that the preparation process was feasible. The stability of ASX-LNC was determined under different conditions, indicating good stability of the ASX-LNC. In antioxidant research, the inhibition rate of free radicals of ASX-LNC was 91.03 ± 0.87% under 250 μg/mL for 30 min, and the inhibition rate of free radicals of astaxanthin ethanol solution was 90.83 ± 1.37%. The antioxidant capacity of astaxanthin was not affected by the encapsulation, which demonstrated the effect of prolonging the release of active ingredients due to the protection of the biological activity of astaxanthin by encapsulation. Compared with the astaxanthin ethanol solution, the ASX-LNC had a slow-release effect and could prolong the action time of active substances. Overall, ASX-LNC is a potential carrier for application in food and health products, which can control the release of active substances. Graphical

chemistry, physical
Controlling release of astaxanthin in β-sitosterol oleogel-based emulsions via different self-assembled mechanisms and composition of the oleogelators

Shujie Wang,Yuyue Qin,Yaping Liu,Guoqin Liu,Guiguang Cheng,Thanapop Soteyome

DOI: https://doi.org/10.1016/j.foodres.2024.114350

Abstract:In this study, three types of β-sitosterol-based oleogels (β-sitosterol + γ-oryzanol oleogels, β-sitosterol + lecithin, oleogels and β-sitosterol + monostearate oleogels), loaded with astaxanthin, were employed as the oil phase to create oleogel-based emulsions (SO, SL, and SM) using high-pressure homogenization. The microstructure revealed that fine-scale crystals were dispersed within the oil phase of the droplets in the β-sitosterol oleogel-based emulsion. The bioaccessibility of astaxanthin was found to be 58.13 %, 51.24 %, 36.57 %, and 45.72 % for SM, SL, SO, and the control group, respectively. Interestingly, the release of fatty acids was positively correlated with the availability of astaxanthin (P = 0.981). Further analysis of FFAs release and kinetics indicated that the structural strength of the oil-phase in the emulsions influenced the degree and rate of lipolysis. Additionally, the micellar fraction analysis suggested that the nature and composition of the oleogelators in SM and SL also impacted lipolysis and the bioaccessibility of astaxanthin. Furthermore, interfacial binding of lipase and isothermal titration calorimetry (ITC) measurements revealed that the oleogel network within the oil phase of the emulsion acted as a physical barrier, hindering the interaction between lipase and lipid. Overall, β-sitosterol oleogel-based emulsions offer a versatile platform for delivering hydrophobic molecules, enhancing the bioavailability of active compounds, and achieving sustained release.
Stable Vesicle Self-Assembled from Phospholipid and Mannosylerythritol Lipid and Its Application in Encapsulating Anthocyanins.

Linlin Fan,Qihe Chen,Yasheng Mairiyangu,Ying Wang,Xiaoli Liu

DOI: https://doi.org/10.1016/j.foodchem.2020.128649

IF: 8.8

2020-01-01

Food Chemistry

Abstract:Stable vesicles were formulated based on the self-assembling of L-alpha-phosphatidylcholine (PC) and mannosylerythritol lipid-A (MEL-A) in a manner of weak or non-cooperative interactions. Their structural characterization, stability and encapsulation properties were evaluated. The results showed that the predominant average diameters varied ranging from 200 nm to 700 nm with MEL-A/PC ratio changed. In case of the ratio at 5:5, 6:4 or 7:3, the vesicles performed the smaller size or turbidity and larger entrapment efficiency for hydrophilic molecules. Anthocyanins were successfully encapsulated using these vesicles, which was confirmed by the formation of egg-shaped structures with the core size less than 500 nm and an encapsulation efficiency of 54.9 +/- 1.6%. Compared with free anthocyanins, the encapsulated anthocyanins displayed higher retention rates when exposed to storage and simulated gastrointestinal fluid conditions, and their antioxidant capacity after simulated intestinal digestion was enhanced by 3-3.5 times because of protection of vesicle encapsulation and possible synergic effects.
Preparation of Astaxanthin Nanodispersions Using Gelatin-Based Stabilizer Systems

Navideh Anarjan,Imededdine Arbi Nehdi,Hassen Mohamed Sbihi,Saud Ibrahim Al-Resayes,Hoda Jafarizadeh Malmiri,Chin Ping Tan,Imededdine Nehdi,Hassen Sbihi,Saud Al-Resayes,Hoda Malmiri,Chin Tan

DOI: https://doi.org/10.3390/molecules190914257

IF: 4.6

2014-09-10

Molecules

Abstract:The incorporation of lipophilic nutrients, such as astaxanthin (a fat soluble carotenoid) in nanodispersion systems can either increase the water solubility, stability and bioavailability or widen their applications in aqueous food and pharmaceutical formulations. In this research, gelatin and its combinations with sucrose oleate as a small molecular emulsifier, sodium caseinate (SC) as a protein and gum Arabic as a polysaccharide were used as stabilizer systems in the formation of astaxanthin nanodispersions via an emulsification-evaporation process. The results indicated that the addition of SC to gelatin in the stabilizer system could increase the chemical stability of astaxanthin nanodispersions significantly, while using a mixture of gelatin and sucrose oleate as a stabilizer led to production of nanodispersions with the smallest particle size (121.4±8.6 nm). It was also shown that a combination of gelatin and gum Arabic could produce optimal astaxanthin nanodispersions in terms of physical stability (minimum polydispersity index (PDI) and maximum zeta-potential). This study demonstrated that the mixture of surface active compounds showed higher emulsifying and stabilizing functionality compared to using them individually in the preparation of astaxanthin nanodispersions.

chemistry, multidisciplinary,biochemistry & molecular biology

Lipid metabolism in relation to cold adaptability in man.

Serotonin axons in the supra- and subependymal plexuses and in the leptomeninges; Their roles in local alterations of cerebrospinal fluid and vasomotor activity

Effect of Membrane Surface Modification Using Chitosan Hydrochloride and Lactoferrin on the Properties of Astaxanthin-Loaded Liposomes

Surface modification by chitosan for improving stability and antioxidative activity of astaxanthin-loaded liposomes

Design of Astaxanthin-Loaded Core-Shell Nanoparticles Consisting of Chitosan Oligosaccharides and Poly(lactic- co-glycolic acid): Enhancement of Water Solubility, Stability, and Bioavailability.

Prevention of Hypercholesterolemia with "Liposomes in Microspheres" Composite Carriers: A Promising Approach for Intestinal-Targeted Oral Delivery of Astaxanthin

Enhancement of Astaxanthin Bioaccessibility by Encapsulation in Liposomes: An In Vitro Study

Preparation, characterization, and stability of chitosan-tremella polysaccharide layer-by-layer encapsulated astaxanthin nanoemulsion delivery system

On trigonometric and paratrigonometric Hermite interpolation

Extraction of Astaxanthin from Haematococcus pluvialis and Preparation of Astaxanthin Liposomes

Lyotropic Liquid Crystal System for Drug Delivery of Astaxanthin: Physical Characterization and Enhanced Antioxidant Potential

Nanostructured Lipid Carriers in Alginate Microgels for the Delivery of Astaxanthin

Preparation of astaxanthin/zeaxanthin-loaded nanostructured lipid carriers for enhanced bioavailability: Characterization-, stability-and permeability study

Preparation of cellulose-based nanoparticles via electrostatic self-assembly for the pH-responsive delivery of astaxanthin

Emotional reactions and life changes of caregivers of demented patients when home caregiving ends

Development of a carboxymethyl chitosan functionalized nanoemulsion formulation for increasing aqueous solubility, stability and skin permeability of astaxanthin using low-energy method

Preparation, characterization and antioxidant activity of astaxanthin esters with different molecular structures

Astaxanthin encapsulation in nanocapsule by high-pressure homogenization technology: a study on stability, antioxidant activity and in vitro release

Controlling release of astaxanthin in β-sitosterol oleogel-based emulsions via different self-assembled mechanisms and composition of the oleogelators

Stable Vesicle Self-Assembled from Phospholipid and Mannosylerythritol Lipid and Its Application in Encapsulating Anthocyanins.

Preparation of Astaxanthin Nanodispersions Using Gelatin-Based Stabilizer Systems